PTEN and breast cancer: Previous studies have described that several mechanisms, including loss of phosphatase and tensin homologue (PTEN) and overexpression of PI3K activation, are involved in regulating PD-L1 expression in breast cancer [27]; and EMT progression induces PD-L1 expression associated metastatic phenotypes.